US EditionMosaic therapeutics expands pipeline with Astex deal
Summary by pharmatimes.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Mosaic Therapeutics in-licenses clinical oncology programmes from Astex Pharma - Pharmafile
Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug combinations. This elevates the research and platform company to a clinical-stage oncology business, bringing products closer to commercialisation and market access. Mosaic now has exclusive rights to develop its combination products in these trials. The […] The post Mosaic Therapeutics in-li…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
